Clinical Trial Update: A Phase I Study of ECO-4601 in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase I study of ECO-4601 in patients with advanced cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioma
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• ECO-4601

Snippet

Sponsor: Thallion Pharmaceuticals | Conditions: Tumors, Glioma | Phase 1 | Status: COMPLETED